Compound ID | 1925
Class: Beta-lactam (aminopenicillin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-positive bacteria and some Enterobacteriaceae, but vulnerable to penicillinases produced by staphylococci and E. coli |
Description: | Semisynthetic penicillin, derived from 6-aminopenicillanic acid (6-APA). Oral (bacampicillin, pivampicillin) and parenteral application. Fixed combination with sulbactam available. |
Institute where first reported: | Sandoz |
Year first mentioned: | 1953 |
Highest developmental phase: | Approved by FDA in 1971 |
Development status: | Approved, off-patent |
Chemical structure(s): | |
Canonical SMILES: | CC1(C)[C@H](C(=O)O)N2C(=O)[C@H]([C@H]2S1)NC(=O)[C@@H](C3=CC=CC=C3)N |
Isomeric SMILES: | CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)N)C(=O)O)C |
InChI: | InChI=1S/C16H19N3O4S/c1-16(2)11(15(22)23)19-13(21)10(14(19)24-16)18-12(20)9(17)8-6-4-3-5-7-8/h3-7,9-11,14H,17H2,1-2H3,(H,18,20)(H,22,23)/t9-,10-,11+,14-/m1/s1 |
InChI Key: | AVKUERGKIZMTKX-NJBDSQKTSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/6249 |